| Literature DB >> 26121165 |
Maria Valkonen1, Inge M Wouters2, Martin Täubel3, Helena Rintala3, Virissa Lenters2, Ritva Vasara3, Jon Genuneit4, Charlotte Braun-Fahrländer5, Renaud Piarroux6, Erika von Mutius7, Dick Heederik2, Anne Hyvärinen3.
Abstract
BACKGROUND: The increase in prevalence of asthma and atopic diseases in Western countries has been linked to aspects of microbial exposure patterns of people. It remains unclear which microbial aspects contribute to the protective farm effect.Entities:
Mesh:
Year: 2015 PMID: 26121165 PMCID: PMC4488145 DOI: 10.1371/journal.pone.0131594
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General characteristics of the study population (n = 224).
| FARM CHILDREN | EXPOSED NON-FARM CHILDREN | NON-EXPOSED NON-FARM CHILDREN | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ASTHMA | NO ASTHMA BUT ATOPY | NO ASTHMA OR ATOPY | ASTHMA | NO ASTHMA BUT ATOPY | NO ASTHMA OR ATOPY | ASTHMA | NO ASTHMA BUT ATOPY | NO ASTHMA OR ATOPY | |
| N | 32 | 23 | 19 | 32 | 22 | 21 | 32 | 21 | 22 |
| Child sex (F/M) | 10 / 22 | 10 / 13 | 13 / 6 | 12 / 20 | 12 / 10 | 6 / 15 | 11 / 21 | 5 / 16 | 9 / 13 |
| Age mean (min-max) | 9.5 (7.5–11.4) | 9.6 (7.4–11.3) | 9.6 (7.5–11.4) | 9.6 (7.3–11.5) | 9.5 (7.4–11.3) | 9.5 (7.4–11.5) | 9.2 (7.1–11.0) | 9.3 (7.8–11.2) | 9.3 (7.3–11.5) |
| No of siblings(0–1 sibling / more than 1 sibling) % | 50 / 50 | 43.5 / 46.5 | 42.1 / 57.9 | 83.9 / 16.1 | 63.6 / 36.4 | 57.1 / 42.9 | 65.6 / 34.4 | 61.9 / 38.1 | 77.3 / 22.7 |
| Parental smoking (no smoking / one or both parents are smoking) % | 78.1 / 21.9 | 91.3 / 8.7 | 61.1 / 38.9 | 69.0 / 31.0 | 81.8 / 18.2 | 57.1 / 42.9 | 71.0 / 29.0 | 71.4 / 28.6 | 76.2 / 23.8 |
Fig 1Flowchart of the study.
Flowchart of molecular analyses (DGGE fingerprinting, quantitative PCR), statistical analyses, and the selection of bands for sequencing and qPCR assays.
Overview of associations between the presence of 43 bacterial taxonomic units (= bands) identified with DNA fingerprinting in mattress dust, and their associations with the health outcomes asthma (6 variables), atopy (5 variables) and eczema (2 variables) and exposure variables (19 variables) (presented are the bands with an association with p<0.05 in Tobit regression analysis, adjusted for age and sex).
| Band number | Health variables | Exposure variables | Selected for sequencing | ||||
|---|---|---|---|---|---|---|---|
| Asthma (6 maximally) | Atopy (5 maximally) | Atopic eczema (2 maximally) | Farming activities | Consump-tion of farm milk | Contact with animal feed | ||
| 35 | 2 out of 2 | x | y | ||||
| Protective | |||||||
| 41 | 3 out of 5 | x | x | y | |||
| Protective | |||||||
| 32 | 2 out of 5 | 1 out of 2 | x | x | y | ||
| Protective | Protective | ||||||
| 36 | 2 out of 5 | x | x | y | |||
| Protective | |||||||
| 17 | 2 out of 5 | x | y | ||||
| Adverse Risk | |||||||
| 24 | 1 out of 2 | x | x | y | |||
| Adverse Risk | |||||||
| 8 | 1 out of 6 | x | x | y | |||
| Protective | |||||||
| 22 | 1 out of 6 | y | |||||
| Protective | |||||||
| 20 | 1 out of 2 | y | |||||
| Adverse Risk, 1 out of 2 Protective | |||||||
| 26 | 1 out of 2 | x | y | ||||
| Protective | |||||||
| 37 | 1 out of 5 | x | y | ||||
| Protective | |||||||
| 38 | 2 out of 5 | 1 out of 2 | x | x | y | ||
| Protective | Protective | ||||||
| 21 | 1 out of 6 | 1 out of 2 | y | ||||
| Protective | Protective | ||||||
| 46 | 2 out of 6 | 2 out of 5 | x | x | x | y | |
| Adverse Risk | Adverse Risk | ||||||
| 33 | x | y | |||||
| 34 | x | x | y | ||||
| 27 | x | x | y | ||||
| 25 | x | x | x | y | |||
| 15 | 1 out of 2 | ||||||
| Protective | |||||||
| 29 | 1 out of 5 | ||||||
| Protective | |||||||
| 39 | 2 out of 5 | ||||||
| Protective | |||||||
| 9 | 1 out of 6 | ||||||
| Protective | |||||||
| 16 | 1 out of 6 | ||||||
| Protective | |||||||
| 7 | x | ||||||
| 14 | x | ||||||
| 18 | x | x | |||||
| 23 | x | ||||||
| 42 | x | ||||||
| 44 | x | ||||||
| 45 | x | x | |||||
| 47 | x | x | |||||
| 48 | x | x | |||||
| 11 | x | ||||||
| Nine bands without associations with atopy, asthma or any of the exposure variables | |||||||
* ‘yes’ to one or more (n/6) of the following six questionnaire items; broad phase 1 asthma definition [= reported wheeze (last 12 months or ever), asthma inhaler use ever, or a reported doctor’s diagnosis of asthma at least once, or wheezy bronchitis at least twice throughout the lifetime], doctor-diagnosed asthma, wheeze in the past 12 months, breathing problems and breathing noises, use of inhaler ever or in the past 12 months.
** ‘yes’ to one or more (n/5) of the following five items; specific IgE serum levels > 0.35kU/L, specific IgE serum levels > 0.7 kU/L, rhinitis symptoms in the past 12 months, rhinoconjunctivitis symptoms in the past 12 months, doctor diagnosed hay fever
*** ‘yes’ to one or two of the following: doctor diagnosed atopic eczema, eczema symptoms in the past 12 months
# ‘yes’to one or more of the following items: child present during milking; cattle care; littering or removing dung; child spent time regular with animals in the stable
† ‘yes’ to: has your child drunk milk directly from a farm regularly (at least once a week for 6 months)?
‡‡ ‘yes’ to: child present while the adults were feeding the animals
x = association (direction not defined) at least with one of the questions
y = yes, band selected to sequencing
¤ = Bands selected for sequencing had significant association with doctor diagnosed asthma or broad phase 1 asthma definition, and/or atopy (cut point 0.7kU/l), and/or atopic eczema. Bands 33, 34, 27, 25 were selected because of their multiple associations with farming factors.
Detailed information on health associations of DGGE bands that were selected for sequencing and taxonomic allocation of sequences retrieved from the bands after database comparison (p-values of associations between DGGE bands and health outcomes are provided both after crude analyses and after FDR adjustment for multiple testing.
| Band number | Associations with health outcomes | p-values | q-values (FDR adjusted) | Sequences retrieved from band with high (≥99%) database similarity | Likely taxonomic allocation | |
|---|---|---|---|---|---|---|
| 35 | Protective | DD atopic eczema | 0.008 | p = 0.099 |
|
|
| Protective | Eczema symptoms | 0.002 | p = 0.083 | |||
| 41 | Protective | Specific IgE >0.7 kU/L | 0.023 |
|
| |
| Protective | Specific IgE >0.35kU/L | 0.027 | ||||
| Protective | DD hay fever | 0.038 | ||||
| 32 | Protective | DD atopic eczema | 0.006 | p = 0.061 |
|
|
| 36 | Protective | Specific IgE >0.7 kU/L | 0.003 | p = 0.088 |
| |
| Protective | Specific IgE >0.35kU/L | 0.002 | ||||
| 17 | Risk | Specific IgE >0.7 kU/L | 0.016 |
|
| |
| Risk | Specific IgE >0.35kU/L | 0.016 | ||||
| 24 | Risk | DD atopic eczema | 0.040 |
|
| |
| 8 | Protective | DD asthma | 0.025 | No sequence information | ||
| 22 | Protective | broad phase 1 asthma definition | 0.008 | p = 0.024 | Ambiguous sequence information, no taxonomic allocation | |
| 20 | Risk | DD eczema | 0.043 | p = 0.001 | No sequence information | |
| Protective | eczema symptoms | 0.000 | ||||
| 26 | Protective | eczema symptoms (past 12 mo) | 0.032 |
|
| |
| 37 | Protective | rhinoconjunctivitis symptoms | 0.040 |
|
| |
| 38 | Protective | Rhinoconjunctivitis symptoms | 0.016 | p = 0.005 |
|
|
| Protective | DD hay fever | 0.030 | ||||
| Protective | eczema symptoms | 0.003 | ||||
| 21 | Protective | inhaler use | 0.040 |
|
| |
| Protective | eczema symptoms | 0.035 | ||||
| 46 | Risk | eczema symptoms | 0.022 | p = 0.080 | No sequence information | |
| Risk | rhinoconjunctivitis symptoms | 0.024 | ||||
| Risk | DD hay fever | 0.011 | ||||
| 33 | No health associations | Ambiguous sequence information, no taxonomic allocation | ||||
| 34 | No health associations |
|
| |||
| 27 | No health associations |
|
| |||
| 25 | No health associations |
|
Only q-values < 0.1are shown).
Levels of microbes detected using qPCR (cells/mg dust) and diversity metrics in three exposure strata stratified by health outcomes.
| FARM CHILDREN | EXPOSED NON-FARM CHILDREN | NON-EXPOSED NON-FARM CHILDREN | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ASTHMA (N = 29) | NO ASTHMA BUT ATOPY (N = 23) | NO ASTHMA OR ATOPY (N = 19) | ASTHMA (N = 30) | NO ASTHMA BUT ATOPY (N = 22) | NO ASTHMA OR ATOPY (N = 18) | ASTHMA (N = 31) | NO ASTHMA BUT ATOPY (N = 20) | NO ASTHMA OR ATOPY (N = 22) | ||
|
| Median | 5573 | 6649 | 4927 | 3679 | 3989 | 4527 | 2284 | 2720 | 3343 |
| (min-max) | (1217–19031) | (2256–22142) | (1325–13239) | (573–12070) | (278–18519) | (559–9075) | (311–16741) | (121–6917) | (363–11967) | |
|
| Median | 35603 | 24654 | 25252 | 17944 | 17703 | 20417 | 44919 | 14668 | 37983 |
| (min-max) | (1052–1.1x10E6) | (1315–286013) | (4051–7.2x10E6) | (2045–948785) | (1247–377892) | (1654–123586) | (3399–806926) | (1227–213290) | (543–566514) | |
|
| Median | 915 | 642 | 554 | 162 | 198 | 192 | 199 | 152 | 620 |
| (min-max) | (3–207616) | (23–36102) | (45–25647) | (6–4116) | (6–1472) | (11–540) | (9–1988) | (11–791) | (2–497132) | |
|
| Median | 1931 | 1682 | 1308 | 343 | 243 | 225 | 340 | 183 | 409 |
| (min-max) | (28–99736) | (42–14942) | (92–40735) | (26–2769) | (2–2062) | (57–1645) | (18–3320) | (45–1415) | (18–3752) | |
| Shannon diversity index | Median | 2.68 | 2.65 | 2.68 | 2.56 | 2.62 | 2.71 | 2.59 | 2.54 | 2.68 |
| (min-max) | (1.89–3.09) | (2.24–2.91) | (2.34–2.88) | (1.93–2.95) | (0.68–3.01) | (2.30–3.05) | (2.36–2.88) | (2.01–3.02) | 1.87–3.04) | |
Fig 2Logistic regression analyses for microbial determinations and atopy.
Survey weighted logistic regression analyses fitted with a cubic spline term for qPCR results (in cells/m2 dust) in mattress dust and probability of atopy (0.7kU/L) in the whole study population. 95% confidence intervals displayed as shaded bands. One extremely small value (outlier) for the Shannon diversity index (0.68) was excluded.